AORT
ARTIVION, INC.
Key Financials
Operating Income
$33.7M
↓ 13.2%
Revenue
$441.3M
↑ 13.6%
Gross Profit
$284.2M
↑ 14.2%
Net Income
$9.8M
↑ 173.1%
EPS (Diluted)
$0.21
↑ 165.6%
Total Assets
$884.8M
↑ 12.1%
Total Liabilities
$436.6M
↓ 14.9%
Shareholders' Equity
$448.2M
↑ 62.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 4/1/2026 | View on SEC |
| DEFA14A | 4/1/2026 | View on SEC |
| DEF 14A | 4/1/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AORT |
| Company Name | ARTIVION, INC. |
| CIK | 784199 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 7704193355 |